Lucile Serfass
About
In The Last Decade
Lucile Serfass
14 papers receiving 825 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 541
- Oncology 232
- Pulmonary and Respiratory Medicine 187
- Cancer Research 122
- Immunology 84
Countries citing papers authored by Lucile Serfass
This map shows the geographic impact of Lucile Serfass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucile Serfass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucile Serfass more than expected).
Fields of papers citing papers by Lucile Serfass
This network shows the impact of papers produced by Lucile Serfass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucile Serfass. The network helps show where Lucile Serfass may publish in the future.
Co-authorship network of co-authors of Lucile Serfass
This figure shows the co-authorship network connecting the top 25 collaborators of Lucile Serfass. A scholar is included among the top collaborators of Lucile Serfass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucile Serfass. Lucile Serfass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 46 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 12 | |
| 7 | 6 | |
| 8 | 5 | |
| 9 | 32 | |
| 10 | 42 | |
| 11 | 4 | |
| 12 | 67 | |
| 13 | Molecular targets and cancer therapeutics. | 4 |
| 14 | Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis breakdown → | 538 |
| 15 | 65 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.